Stanley P - Search Results

1

Novel mimics of sialyl Lewis X: design, synthesis and biological activity of a series of 2- and 3-malonate substituted galactoconjugates.

Marinier A, Martel A, Bachand C, Plamondon S, Turmel B, Daris JP, Banville J, Lapointe P, Ouellet C, Dextraze P, Menard M, Wright JJ, Alford J, Lee D, Stanley P, Nair X, Todderud G, Tramposch KM. Marinier A, et al. Among authors: stanley p. Bioorg Med Chem. 2001 Jun;9(6):1395-427. doi: 10.1016/s0968-0896(01)00015-3. Bioorg Med Chem. 2001. PMID: 11408160

2

Biaryl diacid inhibitors of human s-PLA2 with anti-inflammatory activity.

Springer DM, Luh BY, Bronson JJ, McElhone KE, Mansuri MM, Gregor KR, Nettleton DO, Stanley PL, Tramposch KM. Springer DM, et al. Among authors: stanley pl. Bioorg Med Chem. 2000 May;8(5):1087-109. doi: 10.1016/s0968-0896(00)00047-x. Bioorg Med Chem. 2000. PMID: 10882020

3

BMS-190394, a selectin inhibitor, prevents rat cutaneous inflammatory reactions.

Todderud G, Nair X, Lee D, Alford J, Davern L, Stanley P, Bachand C, Lapointe P, Marinier A, Martel A, Menard M, Wright JJ, Bajorath J, Hollenbaugh D, Aruffo A, Tramposch KM. Todderud G, et al. Among authors: stanley p. J Pharmacol Exp Ther. 1997 Sep;282(3):1298-304. J Pharmacol Exp Ther. 1997. PMID: 9316838

4

Temporal infiltration of leukocyte subsets into mouse skin inflamed with phorbol ester.

Alford JG, Stanley PL, Todderud G, Tramposch KM. Alford JG, et al. Among authors: stanley pl. Agents Actions. 1992 Nov;37(3-4):260-7. doi: 10.1007/BF02028118. Agents Actions. 1992. PMID: 1338267

5

Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate.

Stanley PL, Steiner S, Havens M, Tramposch KM. Stanley PL, et al. Skin Pharmacol. 1991;4(4):262-71. doi: 10.1159/000210960. Skin Pharmacol. 1991. PMID: 1789987

6

Biochemical and pharmacological properties of a new topical anti-inflammatory compound, 9-phenylnonanohydroxamic acid (BMY 30094).

Tramposch KM, Zusi FC, Marathe SA, Stanley PL, Nair X, Steiner SA, Quigley JW. Tramposch KM, et al. Among authors: stanley pl. Agents Actions. 1990 Jun;30(3-4):443-50. doi: 10.1007/BF01966310. Agents Actions. 1990. PMID: 2117339

7

Novel inhibitor of phospholipase A2 with topical anti-inflammatory activity.

Tramposch KM, Steiner SA, Stanley PL, Nettleton DO, Franson RC, Lewin AH, Carroll FI. Tramposch KM, et al. Among authors: stanley pl. Biochem Biophys Res Commun. 1992 Nov 30;189(1):272-9. doi: 10.1016/0006-291x(92)91554-4. Biochem Biophys Res Commun. 1992. PMID: 1449483

8

BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models.

Burke JR, Davern LB, Stanley PL, Gregor KR, Banville J, Remillard R, Russell JW, Brassil PJ, Witmer MR, Johnson G, Tredup JA, Tramposch KM. Burke JR, et al. Among authors: stanley pl. J Pharmacol Exp Ther. 2001 Jul;298(1):376-85. J Pharmacol Exp Ther. 2001. PMID: 11408565

9

1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase.

Combrink KD, Gülgeze HB, Meanwell NA, Pearce BC, Zulan P, Bisacchi GS, Roberts DG, Stanley P, Seiler SM. Combrink KD, et al. Among authors: stanley p. J Med Chem. 1998 Nov 19;41(24):4854-60. doi: 10.1021/jm9804580. J Med Chem. 1998. PMID: 9822554

10

Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.

Tramposch KM, Chilton FH, Stanley PL, Franson RC, Havens MB, Nettleton DO, Davern LB, Darling IM, Bonney RJ. Tramposch KM, et al. Among authors: stanley pl. J Pharmacol Exp Ther. 1994 Nov;271(2):852-9. J Pharmacol Exp Ther. 1994. PMID: 7965805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

899 results

Search Page

Filters